SURVEY: Reasonable agreements between pharmaceutical companies and patient advocatesMPE6 October 2016
MPE encourages EMA to review its negative recommendation for ixazomibAccess, MPE, Myeloma16 August 2016
MPE to hold the “EHA 2016 Highlights in myeloma” webinar on 14th JulyConferences, MPE, Myeloma24 June 2016
MPE present at the XXXVI World Congress of the International Society of HematologyConferences, MPE19 April 2016
Slovak translation of the MPE Report on Myeloma Patient Perspectives is now availableMPE, Patient evidence31 October 2013
Public Launch: MPE report on Myeloma Patients Perspectives (14 June 2013)MPE, Myeloma, Patient evidence14 June 2013
